Key result
Combination therapy with biologic agents in rheumatoid arthritis offers potential clinical benefits but is accompanied by significant risks.
Authors
Loading...
Level 5 evidence is hypothesis-generating; leaves open need for confirmatory trials before any clinical consideration.
Key points are not available for this paper at this time.
Joel M. Kremer (1998) studied this question. Combination therapy with biologic agents in rheumatoid arthritis offers potential clinical benefits but is accompanied by significant risks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: